CERT (Certara) Debt-to-Asset : 0.20 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CERT Certara Inc CERT
65 GF Score
Price $8.14
GF Value $13.33
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Certara Debt-to-Asset?

Certara CERT +0.37% 65 Debt-to-Asset is 0.20 as of Mar. 2026. GuruFocus rates CERT with a GF Score™ of 65/100 and a GF Value™ of $13.33 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Certara's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $3.0 Mil. Certara's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $297.3 Mil. Certara's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2026 was $1,500.4 Mil. Certara's debt to asset for the quarter that ended in Mar. 2026 was 0.20.

Certara  (NAS:CERT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Certara Debt-to-Asset Related Terms

Certara Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Certara's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Certara Debt-to-Asset Chart

Certara Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial 0.20 0.20 0.19 0.20 0.20

Certara Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.20 0.20 0.20 0.20

CERT vs SDGR, OMDA, GDRX: Debt-to-Asset Comparison

For the Health Information Services subindustry, Certara's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Certara Debt-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Certara's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Certara's Debt-to-Asset falls into.


CERT
65GF Score
Certara Inc CERT
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Certara Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Certara's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(7.416 + 298.569) / 1556.582
=0.20

Certara's Debt-to-Asset for the quarter that ended in Mar. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.963 + 297.293) / 1500.368
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.20 mean?
Certara (CERT) has a Debt-to-Asset of 0.20 as of Mar. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Certara and its competitors.
Is Certara's Debt-to-Asset too high?
Certara's current Debt-to-Asset is 0.20. Overall, Certara has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Certara's Debt-to-Asset compare to SDGR and OMDA?
Certara's Debt-to-Asset of 0.20 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Healthcare Providers & Services company?
A good Debt-to-Asset depends on the Healthcare Providers & Services industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Certara and its competitors. Certara's current Debt-to-Asset is 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Based on GuruFocus' analysis, Certara (CERT) is currently considered Significantly Undervalued. The stock's GF Value™ is $13.33, compared to a current price of $8.14 — trading 39% below its estimated fair value. The current Debt-to-Asset is 0.20. Certara's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Certara (CERT), the current Debt-to-Asset is 0.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Certara (CERT) Overvalued in 2026?

Based on GuruFocus' analysis, Certara stock appears to be undervalued. The current stock price of $8.14 is trading 39% below its estimated GF Value™ of $13.33. GuruFocus considers Certara to be Significantly Undervalued.

Key valuation signals for CERT:

  • Debt-to-Asset: 0.20
  • GF Value™: $13.33 vs. price of $8.14 (39% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Certara Business Description

Other Exchanges 700:Germany
Address 4 Radnor Corporate Center, Suite 350, Radnor, PA, USA, 19087
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
65GF Score

Get the complete analysis for CERT

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.14
Price
$13.33
GF Value